Curanex Pharmaceuticals Inc. (CURX) Stock Statistics & Valuation Metrics
Total Valuation
Curanex Pharmaceuticals Inc. has a market cap or net worth of $8.09M. The enterprise value is $5.79T.
- Market Cap
- $8.09M
- Enterprise Value
- $5.79T
Share Statistics
Curanex Pharmaceuticals Inc. has 1,568,241 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,568,241
- Owned by Insiders
- ―
- Owned by Institutions
- 0.12%
Financial Efficiency
Curanex Pharmaceuticals Inc.’s return on equity (ROE) is -0.38 and return on invested capital (ROIC) is -36.65%.
- Return on Equity (ROE)
- -0.38
- Return on Assets (ROA)
- -0.36
- Return on Invested Capital (ROIC)
- -36.65%
- Return on Capital Employed (ROCE)
- -0.37
- Revenue Per Employee
- 0
- Profits Per Employee
- -704.18K
- Employee Count
- 6
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Curanex Pharmaceuticals Inc. is -0.70. Curanex Pharmaceuticals Inc.’s PEG ratio is 0.01.
- PE Ratio
- -0.70
- PS Ratio
- 0.00
- PB Ratio
- 1.53
- Price to FCF
- -0.67
- Price to Operating Cash Flow
- -0.61
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, Curanex Pharmaceuticals Inc. had revenue of 0 and earned -4.23M in profits. Earnings per share was -2.98.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -4.24M
- Pretax Income
- -4.23M
- Net Income
- -4.23M
- EBITDA
- -4.14M
- Earnings Per Share (EPS)
- -2.98
Cash Flow
In the last 12 months, operating cash flow was -12.08M and capital expenditures 0, giving a free cash flow of -12.08M billion.
- Operating Cash Flow
- -12.08M
- Free Cash Flow
- -12.08M
- Free Cash Flow per Share
- -8.52
Dividends & Yields
Curanex Pharmaceuticals Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -149.27%
- Earnings Yield
- -143.05%
Stock Price Statistics
- Beta
- 0.54
- 52-Week Price Change
- -60.91%
- 50-Day Moving Average
- 4.73
- 200-Day Moving Average
- 6.14
- Relative Strength Index (RSI)
- 56.13
- Average Volume (3m)
- 22.53K
Financial Position
Curanex Pharmaceuticals Inc. as a current ratio of 81.93, with Debt / Equity ratio of 3.09%
- Current Ratio
- 81.93
- Quick Ratio
- 81.93
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- 1.12
- Interest Coverage Ratio
- -496.55
Taxes
In the past 12 months, Curanex Pharmaceuticals Inc. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Curanex Pharmaceuticals Inc. EV to EBITDA ratio is -0.52, with an EV/FCF ratio of -0.45.
- EV to Sales
- 0.00
- EV to EBITDA
- -0.52
- EV to Free Cash Flow
- -0.45
- EV to Operating Cash Flow
- -0.45
Balance Sheet
Curanex Pharmaceuticals Inc. has $2.94M in cash and marketable securities with $276.36K in debt, giving a net cash position of $2.66M billion.
- Cash & Marketable Securities
- $2.94M
- Total Debt
- $276.36K
- Net Cash
- $2.66M
- Net Cash Per Share
- $1.70
- Tangible Book Value Per Share
- $3.38
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Curanex Pharmaceuticals Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -2256.41%
